GMP:Blog

 

Here you find current and comprehensive information about Good Manufacturing Practice. Whether mobile phone, tablet or laptop - with the GMP:Blog you stay up to date no matter where you are!

Read the information that is important to you!

This is how it works: Use the drop-down fields to filter the information type, your subject area and the year of publication. You would like to decide even faster which type of information to be displayed to you? Then simply click on the graphics!


Filter Articles: 
10.06.2025 | LOGFILE Feature 12/2025

Water Qualities – Water for Injection (WFI)

5 min. reading time | by Fritz Röder

Production and use

The European Pharmacopoeia defines Water for Injections as water that is intended for use in the manufacture of medicines for parenteral administration whose solvent is water (WFI in bulk), or water that is used to dissolve or dilute substances or preparations for parenteral administration (sterilised WFI). An overview of its potential uses is shown in Figure 1.
 


read more ...
09.06.2025 | QUESTION OF THE WEEK

What is a validation test?


read more ...
06.06.2025 | NEWS

EU: Council Agrees on Position for the 'Pharma Package'

The European Council has adopted its negotiating position on the major reform of EU pharmaceutical laws, the 'Pharma Package', and is now ready to start talks with the European Parliament.


read more ...
06.06.2025 | NEWS

FDA: Launch of “Elsa” AI Tool

The U.S. Food and Drug Administration (FDA) has launched Elsa, a generative AI tool aimed at enhancing the productivity of its employees, from scientists to investigators.


read more ...
27.05.2025 | LOGFILE Feature 11/2025

AI in the GMP Environment: What do the Regulators Expect?

5 min. reading time | by Azade Pütz

Introduction

The rapid development and increasing use of Artificial Intelligence (AI) in the pharmaceutical industry requires a clear regulatory framework to ensure safety, quality, and trustworthiness. In this complex environment, the EU AI Act, relevant ISO standards, and the EMA's reflection paper on the use of AI in the life cycle of medicines play a central role in shaping the regulatory landscape. These instruments aim to find a balanced approach that promotes innovation while minimising potential risks.


read more ...
26.05.2025 | QUESTION OF THE WEEK

What do the abbreviations VP and VR mean?


read more ...
20.01.2025 | AUTHOR

Our Authors

Authors from A to Z: Find an alphabetical list of our authors in the GMP Compliance Adviser. Click here!


read more ...
02.01.2025 | AUTHOR

Dr. Birte Scharf

Birte Scharf, PhD, is a pharmacist and works as a Senior Scientist in the GMP Compliance Team at Franz Ziel GmbH.


read more ...
20.03.2023 | ASK OUR EXPERTS

Ask our Experts

As a subscriber ot the GMP Compliance Adviser, you can ask the editorial team questions at any time. Of course, this is also possible with free demo access.


Do you know? The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business!

 

The demo access ends automatically.

 

>>> Test it now for free


 


read more ...
10.06.2025 | LOGFILE Feature 12/2025

Water Qualities – Water for Injection (WFI)

5 min. reading time | by Fritz Röder

Production and use

The European Pharmacopoeia defines Water for Injections as water that is intended for use in the manufacture of medicines for parenteral administration whose solvent is water (WFI in bulk), or water that is used to dissolve or dilute substances or preparations for parenteral administration (sterilised WFI). An overview of its potential uses is shown in Figure 1.
 


read more ...
06.06.2025 | NEWS

EU: Council Agrees on Position for the 'Pharma Package'

The European Council has adopted its negotiating position on the major reform of EU pharmaceutical laws, the 'Pharma Package', and is now ready to start talks with the European Parliament.


read more ...
27.05.2025 | LOGFILE Feature 11/2025

AI in the GMP Environment: What do the Regulators Expect?

5 min. reading time | by Azade Pütz

Introduction

The rapid development and increasing use of Artificial Intelligence (AI) in the pharmaceutical industry requires a clear regulatory framework to ensure safety, quality, and trustworthiness. In this complex environment, the EU AI Act, relevant ISO standards, and the EMA's reflection paper on the use of AI in the life cycle of medicines play a central role in shaping the regulatory landscape. These instruments aim to find a balanced approach that promotes innovation while minimising potential risks.


read more ...
20.01.2025 | AUTHOR

Our Authors

Authors from A to Z: Find an alphabetical list of our authors in the GMP Compliance Adviser. Click here!


read more ...
20.03.2023 | ASK OUR EXPERTS

Ask our Experts

As a subscriber ot the GMP Compliance Adviser, you can ask the editorial team questions at any time. Of course, this is also possible with free demo access.


Do you know? The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business!

 

The demo access ends automatically.

 

>>> Test it now for free


 


read more ...
09.06.2025 | QUESTION OF THE WEEK

What is a validation test?


read more ...
06.06.2025 | NEWS

FDA: Launch of “Elsa” AI Tool

The U.S. Food and Drug Administration (FDA) has launched Elsa, a generative AI tool aimed at enhancing the productivity of its employees, from scientists to investigators.


read more ...
26.05.2025 | QUESTION OF THE WEEK

What do the abbreviations VP and VR mean?


read more ...
02.01.2025 | AUTHOR

Dr. Birte Scharf

Birte Scharf, PhD, is a pharmacist and works as a Senior Scientist in the GMP Compliance Team at Franz Ziel GmbH.


read more ...

Would you like to read more articles?

Use our useful filter tool!